FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2972317421> ?p ?o ?g. }

• W2972317421 endingPage "623" @default.
• W2972317421 startingPage "615" @default.
• W2972317421 abstract "Abstract Purpose To study whether polypharmacy or drug–drug interactions have differential effect on safety and efficacy in patients treated with direct oral anticoagulants (DOACs) versus warfarin. Methods We performed a systematic review and meta-analysis of studies that randomized patients with atrial fibrillation to DOACs or warfarin stratified by the number of concomitant drugs. Outcomes included stroke or systemic embolism (SE), all-cause mortality, major bleeding, and intracranial hemorrhage. Risk ratios (RR) were calculated and Mantel-Haenszel random effects were applied. Results Two high-quality studies were eligible, including 32,465 participants who received apixaban, rivaroxaban, or warfarin, with a median follow-up of 1.9 years. Of participants, 29% used < 5 drugs, 55% used 5–9 drugs, and 16% used ≥ 10 drugs. Drugs interacting with DOACs (P-glycoprotein/CYP3A4) were used by 6460 (20%) of patients. Patients with higher number of drugs (0–4 vs 5–9 vs ≥ 10) had higher rates of mortality (5.8%, 7.9%, 10.0%) and major bleeding (3.4%, 4.8%, 7.7%). Comparative efficacy or safety of DOACs versus warfarin was not affected by polypharmacy status or P-glycoprotein/CYP3A4 inhibitor use. However, the presence of polypharmacy ( p = 0.001) or glycoprotein/CYP3A4-modulating drugs ( p = 0.03) was correlated with increased risk of major bleeding when compared with warfarin. Overall, DOAC use was associated with a lower risk of stroke/SE (RR, 0.84; 95%CI, 0.74–0.94), all-cause mortality (RR, 0.91; 95%CI, 0.84–0.98), and intracranial hemorrhage (RR, 0.51; 95%CI, 0.38–0.70) compared with warfarin. Conclusions DOACs were more effective than warfarin, and at least as safe. Polypharmacy was associated with adverse outcomes and attenuated the advantage in risk of major bleeding among rivaroxaban users, particularly in the presence of P-glycoprotein/CYP3A4-modulating drugs." @default.
• W2972317421 created "2019-09-19" @default.
• W2972317421 creator A5013410594 @default.
• W2972317421 creator A5033615791 @default.
• W2972317421 creator A5061827631 @default.
• W2972317421 creator A5067237537 @default.
• W2972317421 creator A5088221762 @default.
• W2972317421 date "2019-09-13" @default.
• W2972317421 modified "2023-09-25" @default.
• W2972317421 title "Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation" @default.
• W2972317421 cites W1555088749 @default.
• W2972317421 cites W1956185323 @default.
• W2972317421 cites W1974964541 @default.
• W2972317421 cites W1991833417 @default.
• W2972317421 cites W2025908365 @default.
• W2972317421 cites W2035636901 @default.
• W2972317421 cites W2049678037 @default.
• W2972317421 cites W2102255195 @default.
• W2972317421 cites W2137804367 @default.
• W2972317421 cites W2138426988 @default.
• W2972317421 cites W2143264206 @default.
• W2972317421 cites W2152623033 @default.
• W2972317421 cites W2153054970 @default.
• W2972317421 cites W2164036335 @default.
• W2972317421 cites W2219896033 @default.
• W2972317421 cites W2435303807 @default.
• W2972317421 cites W2509795914 @default.
• W2972317421 cites W2547585100 @default.
• W2972317421 cites W2560438049 @default.
• W2972317421 cites W2583679349 @default.
• W2972317421 cites W2617220065 @default.
• W2972317421 cites W2764121201 @default.
• W2972317421 cites W2787309434 @default.
• W2972317421 cites W2792857103 @default.
• W2972317421 cites W2803081342 @default.
• W2972317421 cites W2957544571 @default.
• W2972317421 cites W3004050106 @default.
• W2972317421 doi "https://doi.org/10.1007/s10557-019-06907-8" @default.
• W2972317421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6904377" @default.
• W2972317421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31520256" @default.
• W2972317421 hasPublicationYear "2019" @default.
• W2972317421 type Work @default.
• W2972317421 sameAs 2972317421 @default.
• W2972317421 citedByCount "39" @default.
• W2972317421 countsByYear W29723174212020 @default.
• W2972317421 countsByYear W29723174212021 @default.
• W2972317421 countsByYear W29723174212022 @default.
• W2972317421 countsByYear W29723174212023 @default.
• W2972317421 crossrefType "journal-article" @default.
• W2972317421 hasAuthorship W2972317421A5013410594 @default.
• W2972317421 hasAuthorship W2972317421A5033615791 @default.
• W2972317421 hasAuthorship W2972317421A5061827631 @default.
• W2972317421 hasAuthorship W2972317421A5067237537 @default.
• W2972317421 hasAuthorship W2972317421A5088221762 @default.
• W2972317421 hasBestOaLocation W29723174211 @default.
• W2972317421 hasConcept C126322002 @default.
• W2972317421 hasConcept C127413603 @default.
• W2972317421 hasConcept C2776301958 @default.
• W2972317421 hasConcept C2778661090 @default.
• W2972317421 hasConcept C2779161974 @default.
• W2972317421 hasConcept C2779384505 @default.
• W2972317421 hasConcept C2780638905 @default.
• W2972317421 hasConcept C2780645631 @default.
• W2972317421 hasConcept C36434225 @default.
• W2972317421 hasConcept C71924100 @default.
• W2972317421 hasConcept C78519656 @default.
• W2972317421 hasConcept C98274493 @default.
• W2972317421 hasConceptScore W2972317421C126322002 @default.
• W2972317421 hasConceptScore W2972317421C127413603 @default.
• W2972317421 hasConceptScore W2972317421C2776301958 @default.
• W2972317421 hasConceptScore W2972317421C2778661090 @default.
• W2972317421 hasConceptScore W2972317421C2779161974 @default.
• W2972317421 hasConceptScore W2972317421C2779384505 @default.
• W2972317421 hasConceptScore W2972317421C2780638905 @default.
• W2972317421 hasConceptScore W2972317421C2780645631 @default.
• W2972317421 hasConceptScore W2972317421C36434225 @default.
• W2972317421 hasConceptScore W2972317421C71924100 @default.
• W2972317421 hasConceptScore W2972317421C78519656 @default.
• W2972317421 hasConceptScore W2972317421C98274493 @default.
• W2972317421 hasIssue "5" @default.
• W2972317421 hasLocation W29723174211 @default.
• W2972317421 hasLocation W29723174212 @default.
• W2972317421 hasLocation W29723174213 @default.
• W2972317421 hasLocation W29723174214 @default.
• W2972317421 hasOpenAccess W2972317421 @default.
• W2972317421 hasPrimaryLocation W29723174211 @default.
• W2972317421 hasRelatedWork W1993190469 @default.
• W2972317421 hasRelatedWork W1993758186 @default.
• W2972317421 hasRelatedWork W2049310472 @default.
• W2972317421 hasRelatedWork W2321904733 @default.
• W2972317421 hasRelatedWork W2489662481 @default.
• W2972317421 hasRelatedWork W2597099584 @default.
• W2972317421 hasRelatedWork W2789710191 @default.
• W2972317421 hasRelatedWork W2896204226 @default.
• W2972317421 hasRelatedWork W2912382166 @default.
• W2972317421 hasRelatedWork W3028955534 @default.
• W2972317421 hasVolume "33" @default.
• W2972317421 isParatext "false" @default.

• next